Charles River Labs Defeats Investor Suit Over Primate Imports

Charles River Laboratories International Inc.‘s statements about its sourcing of non-human primates for pharmaceutical research weren’t misleading, a federal court said in throwing out a proposed investor class action.

Shareholders suing the drugmaker also failed to show the necessary level of intent for securities fraud, Judge Denise J. Casper said Monday for the US District Court for the District of Massachusetts.

Charles River board members are defending a derivative suit with substantially the same allegations of failing to disclose that the company engaged in allegedly illegal import activity. That case has been stayed in anticipation of a ruling in ...